New Novavax, mRNA coronavirus vaccines are approved. Here’s what to know.

Approval of Novavax vaccine targeting JN.1 variant comes days after mRNA coronavirus vaccines from Pfizer-BioNTech and Moderna hit shelves.

View original article
Contributor: Fenit Nirappil